We evaluated changes in patient-reported outcomes and cognitive function from pre- to 3-6 months post-treatment among 42 newly diagnosed patients with multiple myeloma undergoing transplant with complete data using PROMIS-29. There were statistically significant improvements in physical ( < .001) and mental health ( < .001) but not cognition from pre-treatment to 3-6 month follow-up. Similar results were seen within age or comorbidity strata. Patients with myeloma undergoing transplant experienced generally improved short-term health outcomes with no significant declines in cognition.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176031 | PMC |
| http://dx.doi.org/10.1002/jha2.231 | DOI Listing |
Publication Analysis
Top Keywords
patient-reported outcomes
8
patients multiple
8
multiple myeloma
8
outcomes autologous
4
autologous stem
4
stem cell
4
cell transplant
4
transplant patients
4
myeloma evaluated
4
evaluated changes
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!